Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mineralys Therapeutics, Inc.(MLYS) | 7,903,838 | 7,799,518 | -104,320 | $213.25M | $196.00M | 93.45% | -$17.24M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,493,854 | 1,882,039 | +388,185 | $16.21M | $13.74M | 6.55% | -$2.47M |